Safety and efficacy of single-agent ibrutinib in patients with relapsed/refractory (R/R) marginal zone lymphoma (MZL): A multicenter, open-label, phase 2 study Meeting Abstract
| Authors: | Collins, G. P.; Noy, A.; Vos, S.; Thieblemont, C.; Martin, P.; Flowers, C.; Morschhauser, F.; Ma, S.; Coleman, M.; Peles, S.; Smith, S.; Barrientos, J.; Smith, A.; Munneke, B.; Dimery, I.; Beaupre, D.; Chen, R. |
| Abstract Title: | Safety and efficacy of single-agent ibrutinib in patients with relapsed/refractory (R/R) marginal zone lymphoma (MZL): A multicenter, open-label, phase 2 study |
| Meeting Title: | 14th International Conference on Malignant Lymphoma |
| Journal Title: | Hematological Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2017 Jun 14-17 |
| Meeting Location: | Lugano, Switzerland |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2017-06-07 |
| Start Page: | 211 |
| End Page: | 212 |
| Language: | English |
| ACCESSION: | 123459694 |
| DOI: | 10.1002/hon.2438_76 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| DOI/URL: | |
| Notes: | Meeting Abstract: 216 -- Accession Number: 123459694 -- Entry Date: In Process -- Revision Date: 20170608 -- Publication Type: Article -- Supplement Title: Jun2017 Supplement -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: cin20 |
